fda compounding semaglutide warning letter news Democratic lawmakers are pressing the Trump administration to disclose who received special access to Eli Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a to HHS Secretary Robert F FDA issues 30 warning letters
Description
This expansion followed pediatric trial data showing the medication reduced body weight in younger patients, though it also revealed important safety signals that require monitoring during treatment

So naturally, you might assume semaglutide follows the same pattern

Study designs to investigate causality rigorously Prospective new-user cohort with active comparator + Recruit new semaglutide users and matched new users of a comparator second-line diabetes therapy with lower genital infection confounding (e.g., DPP4 inhibitor), stratified by menopausal status and baseline GSM

They can persist for days to a month
Ozempic is a prescription medication originally approved by the FDA for diabetes treatment as a way to help patients control their blood sugar levels

But it does not do the same for drinks
